{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:23:55Z","timestamp":1789709035104,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008398","name":"Villum Fonden","doi-asserted-by":"publisher","award":["9301"],"award-info":[{"award-number":["9301"]}],"id":[{"id":"10.13039\/100008398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","award":["DNRF122"],"award-info":[{"award-number":["DNRF122"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jconrel.2022.11.015","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T08:31:01Z","timestamp":1669278661000},"page":"134-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Oral vaccination using microdevices to deliver \u03b1-GalCer adjuvanted vaccine afford a mucosal immune response"],"prefix":"10.1016","volume":"353","author":[{"given":"Philip H.R.","family":"Carlsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf Bech","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel K.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line Hagner","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Boisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.11.015_bb0005","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.11.015_bb0010","author":"Sexually transmitted infections (STIs)"},{"issue":"4","key":"10.1016\/j.jconrel.2022.11.015_bb0015","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1128\/IAI.01244-13","article-title":"Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection","volume":"82","author":"Rank","year":"2014","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.jconrel.2022.11.015_bb0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/2049-632X.12052","article-title":"Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection","volume":"68","author":"Yeruva","year":"2013","journal-title":"Pathog. Dis."},{"issue":"6","key":"10.1016\/j.jconrel.2022.11.015_bb0025","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1099\/jmm.0.000261","article-title":"Chlamydia trachomatis infection prevalence and serovar distribution in a high-density urban area in the north of Italy","volume":"65","author":"Foschi","year":"2016","journal-title":"J. Med. Microbiol."},{"issue":"8","key":"10.1016\/j.jconrel.2022.11.015_bb0030","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4155\/tde.11.68","article-title":"Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems","volume":"2","author":"Foged","year":"2011","journal-title":"Ther. Deliv."},{"issue":"2","key":"10.1016\/j.jconrel.2022.11.015_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines9020131","article-title":"The immunogenicity of capsid-like particle vaccines in combination with different adjuvants using different routes of administration","volume":"9","author":"Janitzek","year":"2021","journal-title":"Vaccines"},{"issue":"19","key":"10.1016\/j.jconrel.2022.11.015_bb0040","first-page":"1","article-title":"Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide\u202f: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"3099","author":"Abraham","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"November","key":"10.1016\/j.jconrel.2022.11.015_bb0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.smim.2018.10.003","article-title":"Immunocorrelates of CAF family adjuvants","volume":"39","author":"Pedersen","year":"2018","journal-title":"Semin. Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2022.11.015_bb0050","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1128\/IAI.00550-12","article-title":"Vaccine- induced Th17 cells are maintained long-term Postvaccination as a distinct and phenotypically stable memory subset","volume":"80","author":"Lindenstr\u00f8m","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2022.11.015_bb0055","series-title":"Cholera Toxin Subunit B as Adjuvant\u2013\u2013An Accelerator in Protective Immunity and a Break in Autoimmunity","first-page":"579","author":"Stratmann","year":"2015"},{"key":"10.1016\/j.jconrel.2022.11.015_bb0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coph.2018.03.015","article-title":"ADP-ribosylating enterotoxins as vaccine adjuvants","volume":"41","author":"Lycke","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.11.015_bb0065","series-title":"A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine","first-page":"1181","author":"Svindland","year":"2012"},{"issue":"31","key":"10.1016\/j.jconrel.2022.11.015_bb0070","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1016\/j.vaccine.2011.04.094","article-title":"Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4 + cells and strong mucosal and systemic antibody responses in mice","volume":"29","author":"Madhun","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.jconrel.2022.11.015_bb0075","first-page":"1279","article-title":"Dendritic cells pulsed with alpha- galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo","volume":"18","author":"Nagaraj","year":"2006"},{"issue":"45","key":"10.1016\/j.jconrel.2022.11.015_bb0080","article-title":"An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R- dependent Th1 responses","volume":"4","author":"Longet","year":"2019","journal-title":"npj Vaccines"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.11.015_bb0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijpharm.2017.10.013","article-title":"Thermostability of the coating, antigen and immunostimulator in an adjuvanted oral capsule vaccine formulation","volume":"534","author":"Longet","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.11.015_bb0090","series-title":"Current state and challenges in developing oral vaccines","first-page":"116","author":"Ramirez","year":"2018"},{"key":"10.1016\/j.jconrel.2022.11.015_bb0095","article-title":"Oral cholera vaccination promotes homing of IgA + memory B cells to the large intestine and the respiratory tract","volume":"no. February","author":"Van Splunter","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2022.11.015_bb0100","first-page":"1","article-title":"Rede fi ning intestinal immunity with single-cell transcriptomics","volume":"no. July","author":"James","year":"2021"},{"issue":"3","key":"10.1016\/j.jconrel.2022.11.015_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jconrel.2007.04.021","article-title":"PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination","volume":"120","author":"Garinot","year":"2007","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2022.11.015_bb0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.18433\/jpps30965","article-title":"Potential application of ionic liquids in pharmaceutical dosage forms for small molecule drug and vaccine delivery system","volume":"23","author":"Uddin","year":"2020","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"June","key":"10.1016\/j.jconrel.2022.11.015_bb0115","first-page":"1","article-title":"Nano and microparticles as potential oral vaccine carriers and adjuvants against infectious diseases","volume":"12","author":"Jazayeri","year":"2021"},{"issue":"December 2018","key":"10.1016\/j.jconrel.2022.11.015_bb0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2018.11.030","article-title":"Microcontainers for protection of oral vaccines, in vitro and in vivo evaluation","volume":"294","author":"von Halling Laier","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.015_bb0125","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1021\/acsbiomaterials.1c00225","article-title":"X - Ray Imaging for Gastrointestinal Tracking of Microscale Oral Drug Delivery Devices","author":"Kjeldsen","year":"2021","journal-title":"ACI Biomater Sci Eng."},{"key":"10.1016\/j.jconrel.2022.11.015_bb0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mee.2017.01.018","article-title":"Powder embossing method for selective loading of polymeric microcontainers with drug formulation","volume":"171","author":"Abid","year":"2017","journal-title":"Microelectron. Eng."},{"issue":"6","key":"10.1016\/j.jconrel.2022.11.015_bb0135","first-page":"612","article-title":"Practical cone-beam algorithm Sfrdr I _ f","volume":"1","author":"Feldkamp","year":"1984"},{"issue":"6","key":"10.1016\/j.jconrel.2022.11.015_bb0140","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.xphs.2016.03.032","article-title":"Mechanisms of antigen adsorption onto an aluminum-hydroxide adjuvant evaluated by high-throughput screening","volume":"105","author":"Jully","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"25\u201326","key":"10.1016\/j.jconrel.2022.11.015_bb0145","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.vaccine.2009.01.083","article-title":"Alpha- galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens","volume":"27","author":"Courtney","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.11.015_bb0150","series-title":"Vaccine Protocols","first-page":"223","article-title":"Lyophilization of vaccines","author":"Adams","year":"2003"},{"key":"10.1016\/j.jconrel.2022.11.015_bb0155","series-title":"Recommended Best Practices for Lyophilization Validation \u2014 2021 Part I : Process Design and Modeling","first-page":"1","author":"Jameel","year":"2021"},{"issue":"7","key":"10.1016\/j.jconrel.2022.11.015_bb0160","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.xphs.2017.03.014","article-title":"Lyophilized drug product cake appearance: what is acceptable?","volume":"106","author":"Patel","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.11.015_bb0165","series-title":"Lyophilization of Adjuvanted Vaccines: Methods for Formulation of a Thermostable Freeze-Dried Product","first-page":"215","author":"Chan","year":"2017"},{"issue":"4","key":"10.1016\/j.jconrel.2022.11.015_bb0170","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"issue":"September","key":"10.1016\/j.jconrel.2022.11.015_bb0175","first-page":"1","article-title":"Nano-in-Micro-Particles Consisting of PLGA Nanoparticles Embedded in Chitosan Microparticles via Spray-Drying Enhances Their Uptake in the Olfactory Mucosa","volume":"12","author":"Spindler","year":"2021"},{"issue":"2","key":"10.1016\/j.jconrel.2022.11.015_bb0180","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-3659(98)00151-5","article-title":"A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation of drug release using Eudragit\u00ae L100\u201355 and Eudragit\u00ae S100 combinations","volume":"58","author":"Khan","year":"1999","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2022.11.015_bb0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.60.1.0008","article-title":"Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments","volume":"60","author":"McConnell","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.11.015_bb0190","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1021\/acsabm.0c01333","article-title":"Colon-specific delivery of bioactive agents using genipin-cross-linked chitosan coated microcontainers","volume":"4","author":"Kamguyan","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"7","key":"10.1016\/j.jconrel.2022.11.015_bb0195","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1515\/polyeng-2019-0169","article-title":"Swelling behavior and mechanical properties of chitosan-poly(N- vinyl-pyrrolidone) hydrogels","volume":"40","author":"Budianto","year":"2020","journal-title":"J. Polym. Eng."},{"issue":"7","key":"10.1016\/j.jconrel.2022.11.015_bb0200","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.biomaterials.2013.11.073","article-title":"Biomaterials targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan","volume":"35","author":"Jiang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.015_bb0205","series-title":"Colon-targeted delivery of cyclosporine A using dual-functional Eudragit \u00ae FS30D \/ PLGA nanoparticles ameliorates murine experimental colitis","first-page":"1225","author":"Naeem","year":"2018"},{"key":"10.1016\/j.jconrel.2022.11.015_bb0210","article-title":"Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines","volume":"no. February","author":"Davitt","year":"2019","journal-title":"Mucosal Immunol."},{"issue":"15","key":"10.1016\/j.jconrel.2022.11.015_bb0215","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00752-17","article-title":"A self-assembling whole-cell vaccine antigen presentation platform","volume":"200","author":"Liao","year":"2018","journal-title":"J. Bacteriol."},{"issue":"4","key":"10.1016\/j.jconrel.2022.11.015_bb0220","first-page":"312","article-title":"Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia","volume":"29","author":"Concha","year":"1995","journal-title":"Bull. Pan Am. Health Organ."},{"issue":"1","key":"10.1016\/j.jconrel.2022.11.015_bb0225","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/mi.2016.28","article-title":"Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses","volume":"10","author":"Christensen","year":"2017","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.11.015_bb0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41541-019-0129-1","article-title":"Successful application of prime and pull strategy for a therapeutic HSV vaccine","volume":"4","author":"Bernstein","year":"2019","journal-title":"npj Vaccines"},{"issue":"7754","key":"10.1016\/j.jconrel.2022.11.015_bb0235","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41586-019-1125-3","article-title":"Compartmentalized gut lymph node drainage dictates adaptive immune responses","volume":"569","author":"Esterh\u00e1zy","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.11.015_bb0240","series-title":"Gastrointestinal transit measurements in mice with 99m Tc-DTPA-labeled activated charcoal using","first-page":"1","author":"Padmanabhan","year":"2013"},{"issue":"4","key":"10.1016\/j.jconrel.2022.11.015_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12040355","article-title":"Cubic microcontainers improve in situ colonic mucoadhesion and absorption of amoxicillin in rats","volume":"12","author":"Christfort","year":"2020","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.jconrel.2022.11.015_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0183398","article-title":"Comparative analysis of the oral mucosae from rodents and non- rodents: application to the nonclinical evaluation of sublingual immunotherapy products","volume":"12","author":"Thirion-Delalande","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.11.015_bb0255","first-page":"1","article-title":"A mouse intra-intestinal infusion model and its application to the study of nanoparticle distribution","volume":"vol. 7, no. NOV","author":"Sadio","year":"2016","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.11.015_bb0260","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11095-017-2331-z","article-title":"Closed-loop Doluisio (colon, small intestine) and single-pass intestinal perfusion (colon, jejunum) in rat\u2014biophysical model and predictions based on Caco-2","volume":"35","author":"Lozoya-Agullo","year":"2018","journal-title":"Pharm. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922007593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922007593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:32:44Z","timestamp":1759163564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922007593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":52,"alternative-id":["S0168365922007593"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.015","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral vaccination using microdevices to deliver \u03b1-GalCer adjuvanted vaccine afford a mucosal immune response","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}